Celeste Barreto
Overview
Explore the profile of Celeste Barreto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
337
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Constant C, Descalco A, Silva A, Pereira L, Barreto C, Bandeira T
Pulmonology
. 2021 Jun;
27(6):569-571.
PMID: 34092546
No abstract available.
2.
Marcao A, Barreto C, Pereira L, Vaz L, Cavaco J, Casimiro A, et al.
Int J Neonatal Screen
. 2020 Oct;
4(3):22.
PMID: 33072945
Newborn screening (NBS) for cystic fibrosis (CF) has been shown to be advantageous for children with CF, and has thus been included in most NBS programs using various algorithms. With...
3.
Lavorini F, Barreto C, van Boven J, Carroll W, Conway J, Costello R, et al.
J Allergy Clin Immunol Pract
. 2020 Jan;
8(5):1569-1573.
PMID: 31927099
Spacers are pressurized metered-dose inhaler (pMDI) accessory devices developed to reduce problems of poor inhaler technique with pMDIs. Spacers that feature a 1-way inspiratory valve are termed valved holding chambers...
4.
Boon M, Claes I, Havermans T, Fornes-Ferrer V, Calvo-Lerma J, Asseiceira I, et al.
PLoS One
. 2019 Dec;
14(12):e0225004.
PMID: 31860639
Background: Most patients with cystic fibrosis (CF) suffer from pancreatic insufficiency, leading to fat malabsorption, malnutrition and abdominal discomfort. Until recently, no specific tool was available for assessing gastro-intestinal related...
5.
Sousa S, Soares-Castro P, Seixas A, Feliciano J, Balugas B, Barreto C, et al.
N Biotechnol
. 2019 Aug;
54:62-70.
PMID: 31465856
Bacteria of the Burkholderia cepacia complex (Bcc) are ubiquitous multidrug resistant organisms and opportunistic pathogens capable of causing life threatening lung infections among cystic fibrosis (CF) patients. No effective therapies...
6.
Clarke L, Awatade N, Felicio V, Silva I, Calucho M, Pereira L, et al.
Hum Mutat
. 2018 Nov;
40(3):326-334.
PMID: 30488522
A major challenge in cystic fibrosis (CF) research is applying mutation-specific therapy to individual patients with diverse and rare CF transmembrane conductance regulator (CFTR) genotypes. Read-through agents are currently the...
7.
Calvo-Lerma J, Hulst J, Asseiceira I, Claes I, Garriga M, Colombo C, et al.
J Cyst Fibros
. 2017 Mar;
16(4):510-518.
PMID: 28320633
Background: The New European guidelines have established the most updated recommendations on nutrition and pancreatic enzyme replacement therapy (PERT) in CF. In the context of MyCyFAPP project - a European...
8.
Calvo-Lerma J, Martinez-Jimenez C, Lazaro-Ramos J, Andres A, Crespo-Escobar P, Stav E, et al.
BMJ Open
. 2017 Mar;
7(3):e014931.
PMID: 28302638
Introduction: For the optimal management of children with cystic fibrosis, there are currently no efficient tools for the precise adjustment of pancreatic enzyme replacement therapy, either for advice on appropriate...
9.
Sousa S, Morad M, Feliciano J, Pita T, Nady S, El-Hennamy R, et al.
AMB Express
. 2016 Jun;
6(1):41.
PMID: 27325348
Respiratory infections by bacteria of the Burkholderia cepacia complex (Bcc) remain an important cause of morbidity and mortality among cystic fibrosis patients, highlighting the need for novel therapeutic strategies. In...
10.
Coutinho C, Barreto C, Pereira L, Lito L, Cristino J, Sa-Correia I
J Med Microbiol
. 2015 May;
64(8):927-935.
PMID: 26002942
The Burkholderia cepacia complex (Bcc) is a heterogeneous group of bacteria comprising around 20 related species. These bacteria are important opportunistic pathogens, especially in cystic fibrosis (CF) patients, and are...